Experimental Design & Statistical Framework for Life Sciences
Design statistically rigorous experiments with proper controls and sample sizing
What You Can Do
You can design experiments with appropriate controls, replicate structures, and sample sizes before conducting any bench work. This skill helps you establish clear endpoints, identify confounding variables, select the right statistical tests, and create reproducible data collection protocols—preventing costly failed experiments and increasing publishability.
Features
Convert research questions into measurable primary and secondary endpoints with clear success criteria
Design appropriate positive controls, negative controls, and vehicle controls based on study type and mechanisms
Determine minimum n based on effect size, power (typically 80%), significance level, and variance estimates from literature or pilot data
Match your study design and data type to parametric or non-parametric tests (t-tests, ANOVA, Mann-Whitney U, Kruskal-Wallis, etc.)
Map potential sources of bias (batch effects, circadian rhythms, operator effects, environmental factors) and design mitigation strategies
Build in technical replicates, biological replicates, and randomization protocols for robust results
Ensure design aligns with GLP principles and FDA/EMA expectations for IND/CTA submissions
Debug high variability or failed experiments by analyzing flaws in prior experimental architecture
Example Output
Example 1: Dose-Response Study
Prompt: "Design a dose-response experiment for a new therapeutic candidate. We expect 40% efficacy improvement at the optimal dose, baseline efficacy is 20%, and historical CV is 25%."
Output includes:
- Primary endpoint: % efficacy improvement vs. vehicle control
- Study arms: Vehicle, 3 dose levels (0.1x, 1x, 10x estimated therapeutic dose), positive control
- Sample size: n=12 per group (80% power, α=0.05, two-tailed)
- Statistical test: One-way ANOVA with Dunnett's post-hoc for vehicle comparison
- Controls: Positive control compound, vehicle-matched formulation, environmental controls (temperature, humidity)
- Randomization: Stratified by treatment block, counterbalanced order
Example 2: Mechanism Study with Confounding Variables
Prompt: "We're investigating whether compound X improves cardiac function through AMPK activation. What confounding variables should we control?"
Output includes:
- Primary confounders: Sex, age, baseline metabolic state, fed/fasted status
- Technical confounders: Circadian rhythm effects (measure at same time), operator variability (blinding protocol), equipment drift (daily calibration)
- Recommended design: Sex-stratified analysis, randomized measurement times, blinded operator assessment, environmental chamber for circadian control
- Sample size adjustment: +25% to account for stratification by sex
Example 3: Troubleshooting High Variability
Prompt: "Our PK/PD study showed unexpected high variability (CV >40%). We used n=6 per group. What went wrong in our design?"
Output includes:
- Design flaws identified: Insufficient n (underpowered for detection), no stratification by sex (known PK differences), no fasting standardization, measurement times inconsistent
- Revised design: n=12 per sex, fasted animals only, fixed measurement windows ±15 min
- New power calculation: 80% power to detect 35% efficacy change with revised n and CV estimate
What's Included
- SKILL.md: Full experimental design framework with hypothesis-to-analysis workflow
- Study Design Template: Section-by-section guide covering rationale, endpoints, arms, sample size, controls, randomization, and statistical plan
- Sample Size Calculator Guide: Step-by-step instructions for calculating n using effect size, power, and variance; includes interpretation of common assumptions
- Statistical Test Decision Tree: Flowchart matching study design type, data distribution, and number of groups to appropriate parametric or non-parametric tests
- Confounding Variable Checklist: Comprehensive list of biological, technical, and environmental confounders by experiment type (in vivo, in vitro, PK/PD, mechanistic)
- Regulatory Compliance Checklist: GLP alignment, control requirements, randomization documentation, and FDA/EMA expectations for submissions
Who It's For
- Research Scientists — Designing preclinical or clinical studies with robust statistical foundations
- Biotech R&D Managers — Planning study portfolios and ensuring methodological rigor before resource allocation
- Regulatory Affairs Specialists — Ensuring study designs meet GLP and regulatory expectations for IND/CTA submissions
- Academic Researchers — Building publishable studies with peer-review-ready experimental design and statistical rigor
- Principal Investigators — Managing multiple concurrent studies and troubleshooting high-variability results
Best For
- Designing dose-response, time-course, and efficacy studies before bench work begins
- Planning PK/PD and biomarker investigation studies with multiple arms and endpoints
- Calculating minimum sample sizes based on power, effect size, and variance estimates
- Selecting appropriate statistical tests matched to study design and data type
- Troubleshooting failed or high-variability experiments by auditing experimental architecture
- Responding to peer-review or regulatory feedback questioning study design rigor
You might also like
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-w
You can architect end-to-end bioinformatics analysis pipelines by translating your research question into algorithmic approaches, selecting and optimizing appropriate tools and parameters for your dataset, and validating results against biological expectations. This skill guides you through the complete decision tree from raw data to publication-ready interpretation, helping you avoid parameter overfitting, misinterpreted statistical thresholds, and algorithm selection errors that compromise research validity.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-wClaude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
You can upload or describe product designs and receive a comprehensive analysis of manufacturing feasibility, cost drivers, and prioritized optimization recommendations. The skill identifies design inefficiencies, material waste opportunities, assembly complexity challenges, and supply chain risks—giving you actionable steps to reduce costs and prevent production delays before they happen.
by kody-w
This skill organizes complex toxicology datasets, clinical adverse events, and mechanistic findings into structured, FDA/EMA-compliant safety narratives. You input raw safety data—adverse event summaries, laboratory results, animal study findings, vital signs—and receive draft safety summaries, detailed safety assessments, and expedited safety reports ready for regulatory submission. It handles IND applications, annual safety updates, clinical development safety overviews, and urgent safety communications with proper MedDRA coding and regulatory formatting.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w